These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6471663)

  • 1. [Malignant pheochromocytoma: blood pressure controlled by labetalol].
    Sugano O; Hirano J; Hirano K; Kubota Y; Numasawa K; Kawamura S
    Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):523-7. PubMed ID: 6471663
    [No Abstract]   [Full Text] [Related]  

  • 2. Labetalol in the treatment of a patient with phaechromocytoma: a case report.
    Bailey RR
    Br J Clin Pharmacol; 1979; 8(Suppl 2):141S-142S. PubMed ID: 526394
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pheochromocytoma treated with combined alpha-beta blockader].
    Nyberg G; Waldenström J; Vedin A
    Lakartidningen; 1979 Jun; 76(23):2248-50. PubMed ID: 459631
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical effects of labetalol on pheochromocytoma].
    Yoshinaga K; Arakawa K; Ando H; Iai F; Ikeda M
    Horumon To Rinsho; 1983 Feb; 31(2):183-92. PubMed ID: 6340865
    [No Abstract]   [Full Text] [Related]  

  • 5. [Labetalol in the intraoperative control of pheochromocytoma].
    Janjić I; Luetić V
    Lijec Vjesn; 1983; 105(7-8):304-6. PubMed ID: 6633151
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of labetalol during anesthesia for pheochromocytoma removal.
    Van Stratum M; Levarlet M; Lambilliotte JP; Lignian H; de Rood M
    Acta Anaesthesiol Belg; 1983 Dec; 34(4):233-40. PubMed ID: 6673473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effects of labetalol in 21 patients with phaeochromocytoma (author's transl)].
    Yoshinaga K; Arakawa K; Ikeda M; Ebihara T; Oe N
    Horumon To Rinsho; 1981 Apr; 29(4):515-22. PubMed ID: 7296922
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA; Brown JJ; Lever AF; Robertson AS; Robertson JI; Trust PM
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.
    Reach G; Thibonnier M; Chevillard C; Corvol P; Milliez P
    Br Med J; 1980 May; 280(6227):1300-1. PubMed ID: 7388518
    [No Abstract]   [Full Text] [Related]  

  • 10. Labetalol: the nineteen-eighties.
    Robertson JI
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):137S-141S. PubMed ID: 7093098
    [No Abstract]   [Full Text] [Related]  

  • 11. Labetalol and the management of hypertension.
    Reid JL; Meredith PA; Elliott HL
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S60-8. PubMed ID: 6169961
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertensive response to labetalol in phaeochromocytoma.
    Briggs RS; Birtwell AJ; Pohl JE
    Lancet; 1978 May; 1(8072):1045-6. PubMed ID: 76965
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recurrent hypertensive crises and dyspnea following unilateral adrenalectomy in pheochromocytoma in a 44-year-old patient. Successful combination chemotherapy of malignant pheochromocytoma].
    Saller B; Jacob K; Markl A; Zwiebel FM; Engelhardt D; Mann K
    Internist (Berl); 1990 Jan; 31(1):78-81. PubMed ID: 2307558
    [No Abstract]   [Full Text] [Related]  

  • 14. An unusual presentation of a pheochromocytoma.
    Lewis S; Dirnhuber M; Soar J
    J Cardiothorac Vasc Anesth; 2006 Jun; 20(3):390-3. PubMed ID: 16750743
    [No Abstract]   [Full Text] [Related]  

  • 15. Labetalol and phaeochromocytoma.
    Navaratnarajah M; White DC
    Br J Anaesth; 1984 Oct; 56(10):1179. PubMed ID: 6477797
    [No Abstract]   [Full Text] [Related]  

  • 16. [Absence of labetalol interference on urine metanephrine determination in hypertensive patients].
    Girerd X; Billaud EM; Sorrel-Dejerine A; Ropers J; Safavian A; Safar M; Laurent S
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1231-4. PubMed ID: 1482264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metastatic malignant pheochromocytoma: treatment with alpha-methyl-para-tyrosine].
    Tcherdakoff P; Ménard J; Bedrossian J; Vaysse J; Alexandre JM; Milliez P
    Sem Hop; 1972 May; 48(25):1779-87. PubMed ID: 4405188
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenal phaeochromocytoma in familial neurofibromatosis with initial control of hypertension by labetalol.
    Stewart PA
    J R Soc Med; 1982 Apr; 75(4):276-8. PubMed ID: 6802972
    [No Abstract]   [Full Text] [Related]  

  • 19. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
    Rosei EA; Fraser R; Morton JJ; Brown JJ; Lever AF; Robertson JI; Trust PM
    Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
    [No Abstract]   [Full Text] [Related]  

  • 20. Labetalol: a review of its pharmacology and therapeutic use in hypertension.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Apr; 15(4):251-70. PubMed ID: 25757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.